Loading...

TARS TARSUS PHARMACEUTICALS INC Operational Disruptions 8-K Filing

TRSS

TRS

TARSUS PHARMACEUTICALS INC

(TARS)

2023 8-K

Show Summary

Show Summary

Financial Statements

Financial Results

Corporate Presentation

New Lease Agreement

Financial Results

Management Change

Financial Results

Annual Meeting of Stockholders

Financial Results

Underwriting Agreement

Earnings Reports

Departure of Chief Medical ...

Publication of Corporate Pr...

Clinical Trial Results

Earnings Reports

Financial Results

Underwriting Agreement

New Product Launches

Annual Meeting of Stockholders

Virtual Investor Webcast

Financial Results

Management Changes

Financial Results

Entry into Material Definit...

External Links:

Tarsus Pharmaceuticals announces positive results of Phase 2a clinical trial for treatment of Meibomian Gland Disease.

AI Assistant

TARSUS PHARMACEUTICALS INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.